Contact
searchSearch
HMP Global

Cancer Care Business Exchange

Cancer Care Business Breakthroughs

VIDEO
CCM Video Thumbnail
Videos
Care Management Programs vs Value-Based Programs: The Path Forward
09/28/2023
Barry Russo, MBA; Brandy Manning, MSN, RN, OCN; Tanya Park; Amy Valley, PharmD
In this Cancer Care Business Breakthroughs, Barry Russo, MBA, spoke with Brandy Manning, MSN, RN, OCN; Amy Valley, PharmD; and Tanya Park about why many oncology practices opted out of the Enhancing Oncology Model and what tools and resources...
In this Cancer Care Business Breakthroughs, Barry Russo, MBA, spoke with Brandy Manning, MSN, RN, OCN; Amy Valley, PharmD; and Tanya Park about why many oncology practices opted out of the Enhancing Oncology Model and what tools and resources...
In this Cancer Care Business...
09/28/2023
Cancer Care Business Exchange
VIDEO
John Hennessy Headshot
Videos
Biosimilars, Explained
08/28/2023
John Hennessy, MBA
John Hennessy, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
John Hennessy, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
John Hennessy, MBA, Valuate...
08/28/2023
Cancer Care Business Exchange
VIDEO
Stop-Loss Insurance, Explained Thumbnail
Videos
Stop-Loss Insurance, Explained
08/07/2023
John Hennessy, MBA
John Hennessy, MBA, Valuate Health Consultancy, gives an overview of stop-loss or provider-excess insurance: what it is, why more oncology providers are considering it, and the pros and cons.
John Hennessy, MBA, Valuate Health Consultancy, gives an overview of stop-loss or provider-excess insurance: what it is, why more oncology providers are considering it, and the pros and cons.
John Hennessy, MBA, Valuate...
08/07/2023
Cancer Care Business Exchange
VIDEO
Health Care Sharing Plans, Explained Thumbnail
Videos
Health Care Sharing Programs, Explained
07/25/2023
John Hennessy, MBA
John Hennessy, MBA, Valuate Health Consultancy, describes health care sharing programs and why 1.7 million Americans are choosing this option over traditional health insurance.
John Hennessy, MBA, Valuate Health Consultancy, describes health care sharing programs and why 1.7 million Americans are choosing this option over traditional health insurance.
John Hennessy, MBA, Valuate...
07/25/2023
Cancer Care Business Exchange
VIDEO
CBEX EOM video thumbnail.
Videos
The Enhancing Oncology Model: Stakeholder Perspectives on EOM Prelaunch
06/14/2023
Ron Barkley, MS, JD, from the Cancer Center Business Development Group, speaks with Marissa Rivera, MBA, Ventura County Hematology Oncology Specialists; Alexandra Chong, PhD, Center for Medicare & Medicaid Innovation; Barry Russo, MBA,...
Ron Barkley, MS, JD, from the Cancer Center Business Development Group, speaks with Marissa Rivera, MBA, Ventura County Hematology Oncology Specialists; Alexandra Chong, PhD, Center for Medicare & Medicaid Innovation; Barry Russo, MBA,...
Ron Barkley, MS, JD, from the...
06/14/2023
Cancer Care Business Exchange
VIDEO
CBEX Risant Health Video thumbnail.
Videos
Industry Consolidation: Risant Health, A National Network for Value-Based Care
06/06/2023
In this Cancer Care Business Breakthroughs video, Ron Barkley, MS, JD, Cancer Center Business Development Group, is joined by Barry Russo, MBA, The Center for Cancer and Blood Disorders; Erich Mounce, MHA, Oncology Care Partners; Barbara...
In this Cancer Care Business Breakthroughs video, Ron Barkley, MS, JD, Cancer Center Business Development Group, is joined by Barry Russo, MBA, The Center for Cancer and Blood Disorders; Erich Mounce, MHA, Oncology Care Partners; Barbara...
In this Cancer Care Business...
06/06/2023
Cancer Care Business Exchange
The Sleeping Giant: Cost of Cancer Care Rousing Self-Insured Employers
Cancer Care Business Breakthroughs Video 2
The Sleeping Giant: Cost of Cancer Rousing Self-Insured Employers
Self-Insured Employers, Explained
01/12/2023
Deirdre Saulet, PhD, Carrum Health, provides an overview of self-insured employers, including a definition of the term, statistics on why more employers are going the self-insured route, and why the cost of cancer care is such a big concern.
Deirdre Saulet, PhD, Carrum Health, provides an overview of self-insured employers, including a definition of the term, statistics on why more employers are going the self-insured route, and why the cost of cancer care is such a big concern.
Deirdre Saulet, PhD, Carrum...
01/12/2023
Cancer Care Business Exchange
The Sleeping Giant: Cost of Cancer Rousing Self-Insured Employers
Cancer Care Business Breakthroughs Video 1
The Sleeping Giant: Cost of Cancer Rousing Self-Insured Employers
Supporting the Employee Journey Through Cancer: Carrum Health and AccessHope's Partnership
12/15/2022
Erich Mounce, MHA, Oncology Care Partners, speaks with Dr. Deirdre Saulet, Carrum Health, and Dr. Harlan Levine, AccessHope, to discuss the recently announced partnership between Carrum Health and AccessHope. This partnership aims to help...
Erich Mounce, MHA, Oncology Care Partners, speaks with Dr. Deirdre Saulet, Carrum Health, and Dr. Harlan Levine, AccessHope, to discuss the recently announced partnership between Carrum Health and AccessHope. This partnership aims to help...
Erich Mounce, MHA, Oncology Care...
12/15/2022
Cancer Care Business Exchange

Clinical Pathways Congress

CONFERENCE COVERAGE
CAR T-Cell Therapy and Bispecifics in the Community: Opportunities and Obstacles
10/22/2025
Lavi Kwiatkowsky
At CPC+CBEx 2025, Lavi Kwiatkowsky discussed how payer frameworks, accreditation requirements, and operational challenges are shaping access to CAR T-cell and bispecific therapies in community oncology—and how technology could bridge the gap...
At CPC+CBEx 2025, Lavi Kwiatkowsky discussed how payer frameworks, accreditation requirements, and operational challenges are shaping access to CAR T-cell and bispecific therapies in community oncology—and how technology could bridge the gap...
At CPC+CBEx 2025, Lavi...
10/22/2025
Journal of Clinical Pathways
Gilmore
Interview
Pharmacy-Driven Pathways: Enhancing Efficacy, Tolerability, and Value in Oncology Care
10/17/2025
James Gilmore, PharmD
At CPC+CBEx 2025, James Gilmore, PharmD, discussed how the American Oncology Network is elevating pharmacist-driven clinical pathways through data, technology, and collaboration to advance value-based care and enhance patient safety with...
At CPC+CBEx 2025, James Gilmore, PharmD, discussed how the American Oncology Network is elevating pharmacist-driven clinical pathways through data, technology, and collaboration to advance value-based care and enhance patient safety with...
At CPC+CBEx 2025, James Gilmore,...
10/17/2025
Journal of Clinical Pathways
ONLINE EXCLUSIVES
CPC+CBEx Abstracts
10/15/2025
For this year's Clinical Pathways Congress + Cancer Care Business Exchange (CPC+CBEx), authors contributed research that presented real-world evidence, conceptual models, and proposals designed to inform the development and refinement of...
For this year's Clinical Pathways Congress + Cancer Care Business Exchange (CPC+CBEx), authors contributed research that presented real-world evidence, conceptual models, and proposals designed to inform the development and refinement of...
For this year's Clinical...
10/15/2025
Journal of Clinical Pathways
Kuntz
Conference Coverage
Defining the Future of Predictable Cost of Care: Insights from Phase 2
10/10/2025
Gordon Kuntz
The Predictable Cost of Care (PCC) Working Group is expanding its economic models to include patient-centric metrics by developing a parallel track that measures patient time, healthcare interactions, and variability in coverage, aiming to...
The Predictable Cost of Care (PCC) Working Group is expanding its economic models to include patient-centric metrics by developing a parallel track that measures patient time, healthcare interactions, and variability in coverage, aiming to...
The Predictable Cost of Care...
10/10/2025
Journal of Clinical Pathways
Tremonti Headshot
Videos
Evolving Pathways: How Stakeholder Collaboration is Shaping the PCC Model
10/08/2025
Carole Tremonti, RN, MBA
From expanding stakeholder collaboration to tackling data transparency and real-world model testing, the Predictable Cost of Care initiative is transforming how clinical pathways are developed and decisions are driven by data.
From expanding stakeholder collaboration to tackling data transparency and real-world model testing, the Predictable Cost of Care initiative is transforming how clinical pathways are developed and decisions are driven by data.
From expanding stakeholder...
10/08/2025
Journal of Clinical Pathways
Videos
Real-World Evidence in Action: Insights from CPC+CBEx 2025
10/02/2025
Lalan Wilfong, MD; Aimee Ginsburg, PharmD, BCPS
In this CPC+CBEx 2025 interview, experts Lalan Wilfong, MD, and Aimee Ginsburg Chesnick, PharmD, BCPS, explore how real-world evidence is shaping drug approvals, clinical decision-making, and future opportunities for stronger, more actionable...
In this CPC+CBEx 2025 interview, experts Lalan Wilfong, MD, and Aimee Ginsburg Chesnick, PharmD, BCPS, explore how real-world evidence is shaping drug approvals, clinical decision-making, and future opportunities for stronger, more actionable...
In this CPC+CBEx 2025 interview,...
10/02/2025
Journal of Clinical Pathways
Conference Coverage
Real-World Evidence in Oncology: Opportunities, Challenges, and Clinical Impact
09/10/2025
Grace Taylor, MS, MA
In this CPC+CBEx session, experts debate how real-world evidence can complement clinical trials, accelerate regulatory approvals, and reshape patient care.
In this CPC+CBEx session, experts debate how real-world evidence can complement clinical trials, accelerate regulatory approvals, and reshape patient care.
In this CPC+CBEx session,...
09/10/2025
Journal of Clinical Pathways
Conference Coverage
Building a Transparent Framework for Predictable Cost of Care in Oncology Pathways
09/10/2025
Hannah Musick
The Predictable Cost of Care initiative is creating a transparent, standardized model to quantify the true, incremental costs of cancer therapies—enabling more informed, equitable, and efficient decision-making across pathways, payers, and...
The Predictable Cost of Care initiative is creating a transparent, standardized model to quantify the true, incremental costs of cancer therapies—enabling more informed, equitable, and efficient decision-making across pathways, payers, and...
The Predictable Cost of Care...
09/10/2025
Journal of Clinical Pathways
Conference Coverage
Reviewing a Decade of Oncology Pathways: Standardization, Gaps, and the Road to Real-Time Intelligence
09/09/2025
Hannah Musick
A decade after the American Society of Clinical Oncology’s (ASCO’s) original guidance, oncology pathways are maturing into powerful tools for standardizing care, but gaps in disease coverage, workflow integration, and real-time adaptability...
A decade after the American Society of Clinical Oncology’s (ASCO’s) original guidance, oncology pathways are maturing into powerful tools for standardizing care, but gaps in disease coverage, workflow integration, and real-time adaptability...
A decade after the American...
09/09/2025
Journal of Clinical Pathways
Conference Coverage
How AI is Reshaping Clinical Practice, Governance, and Patient Trust
09/09/2025
Grace Taylor, MS, MA
From streamlining documentation to reshaping prior authorization, a panel of experts reveal how artificial intelligence (AI) is changing the realities of cancer care—and the challenges that come with it.
From streamlining documentation to reshaping prior authorization, a panel of experts reveal how artificial intelligence (AI) is changing the realities of cancer care—and the challenges that come with it.
From streamlining documentation...
09/09/2025
Journal of Clinical Pathways

Journal of Clinical Pathways

Videos
Driving Innovation in Cancer Care: The Future of Value-Based Care in Oncology
12/04/2024
Gordon Kuntz
In this interview, Gordon Kuntz discusses the Delphi Method, a Predictable Cost of Care Model developed by the Predictable Cost of Care Working Group that enhances oncology market access strategies by standardizing and broadening the economic...
In this interview, Gordon Kuntz discusses the Delphi Method, a Predictable Cost of Care Model developed by the Predictable Cost of Care Working Group that enhances oncology market access strategies by standardizing and broadening the economic...
In this interview, Gordon Kuntz...
12/04/2024
Journal of Clinical Pathways
Videos
Building Consensus for Predictable Cancer Care Costs: Applying the Delphi Method to Multidisciplinary Stakeholder Collaboration
12/02/2024
Carole Tremonti, RN, MBA
In this interview, Carole Tremonti, RN, MBA, discusses the critical role of clinical pathways in equitable cancer care, the application of the Delphi Method by the Predictable Cost of Care Working Group to foster multidisciplinary...
In this interview, Carole Tremonti, RN, MBA, discusses the critical role of clinical pathways in equitable cancer care, the application of the Delphi Method by the Predictable Cost of Care Working Group to foster multidisciplinary...
In this interview, Carole...
12/02/2024
Journal of Clinical Pathways
Videos
The Evolving Role of Pharmacists in Custom Pathway Implementation
11/25/2024
Rebecca Maniago, PharmD, BCOP
In this interview, Rebecca Maniago, PharmD, discusses the complexities of implementing custom clinical pathways, emphasizing the need for clear goals, robust resources, and ongoing updates, while highlighting the pivotal role of pharmacists...
In this interview, Rebecca Maniago, PharmD, discusses the complexities of implementing custom clinical pathways, emphasizing the need for clear goals, robust resources, and ongoing updates, while highlighting the pivotal role of pharmacists...
In this interview, Rebecca...
11/25/2024
Journal of Clinical Pathways
Kolodziej Headshot
Videos
Understanding the Impact of Venture Capital and Private Equity in Oncology
11/18/2024
Michael Kolodziej, MD
Michael Kolodziej, MD, discusses the growing influence of venture capital and private equity in oncology care, highlighting the potential for these trends to reshape costs, partnerships, and innovation in the oncology landscape.
Michael Kolodziej, MD, discusses the growing influence of venture capital and private equity in oncology care, highlighting the potential for these trends to reshape costs, partnerships, and innovation in the oncology landscape.
Michael Kolodziej, MD, discusses...
11/18/2024
Journal of Clinical Pathways
Videos
Evolving Oncology Pathways, CLL Treatment Advances, and the Role of Multidisciplinary Care Teams
11/12/2024
Shaffee Bacchus, PharmD
Shaffee Bacchus, PharmD, discusses the evolution of oncology pathways, advancements in chronic lymphocytic leukemia (CLL) treatment, and the importance of multidisciplinary care teams in addressing comorbidities and enhancing patient quality...
Shaffee Bacchus, PharmD, discusses the evolution of oncology pathways, advancements in chronic lymphocytic leukemia (CLL) treatment, and the importance of multidisciplinary care teams in addressing comorbidities and enhancing patient quality...
Shaffee Bacchus, PharmD,...
11/12/2024
Journal of Clinical Pathways
Videos
Navigating Multidisciplinary Care: Insights on Oncology Practice Integration and Pharmaceutical Partnerships
11/04/2024
John Hennessy, MBA
John Hennessy, Principal at Valuate Health Consultancy, highlights the importance of multidisciplinary collaboration in oncology care to improve patient outcomes.
John Hennessy, Principal at Valuate Health Consultancy, highlights the importance of multidisciplinary collaboration in oncology care to improve patient outcomes.
John Hennessy, Principal at...
11/04/2024
Journal of Clinical Pathways
Videos
Custom Pathways in Oncology: Innovations, Stakeholder Collaboration, and Value-Based Care
11/01/2024
James Hamrick, MD, MPH
James Hamrick, MD, MPH, Vice President of Clinical Oncology at Flatiron Health, highlights the importance of custom oncology pathways in enabling real-time updates for oncologists, fostering collaborative implementation teams, and supporting...
James Hamrick, MD, MPH, Vice President of Clinical Oncology at Flatiron Health, highlights the importance of custom oncology pathways in enabling real-time updates for oncologists, fostering collaborative implementation teams, and supporting...
James Hamrick, MD, MPH, Vice...
11/01/2024
Journal of Clinical Pathways
News
ONCare Alliance Emerges as a Transformative Force in Independent Oncology and Cancer Care
02/29/2024

Brandon Twyford

Brandon Twyford
Two leading oncology care organizations, the National Cancer Care Alliance (NCCA) and Quality Clinical Cancer Associates (QCCA), have joined forces to create ONCare Alliance, LLC.
Two leading oncology care organizations, the National Cancer Care Alliance (NCCA) and Quality Clinical Cancer Associates (QCCA), have joined forces to create ONCare Alliance, LLC.
Two leading oncology care...
02/29/2024
Cancer Care Business Exchange
Ira Klein, MD.
Videos
AI in Health Care: Foundations, Myths, and Practical Applications
02/07/2024
Ira Klein, MD, MBA, FACP
Ira Klein, MD, MBA, vice president of medical affairs for Tempus Labs, provides insight into the future of AI in health care and how it will help cut down on mundane tasks and increase oncologists’ efficiency.
Ira Klein, MD, MBA, vice president of medical affairs for Tempus Labs, provides insight into the future of AI in health care and how it will help cut down on mundane tasks and increase oncologists’ efficiency.
Ira Klein, MD, MBA, vice...
02/07/2024
Journal of Clinical Pathways
Harlan Levine, MD
Videos
Expanding Access to Care Through Academic-Community Cancer Care Collaboration
01/23/2024
Harlan Levine, MD
Harlan Levine, MD, highlights the benefits of the collaboration between community cancer centers and academic medical centers, including allowing for more access to patient care.
Harlan Levine, MD, highlights the benefits of the collaboration between community cancer centers and academic medical centers, including allowing for more access to patient care.
Harlan Levine, MD, highlights...
01/23/2024
Journal of Clinical Pathways

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use